Target type: biologicalprocess
Any process that stops, prevents or reduces the frequency, rate or extent of cytoplasmic translational initiation. [GO_REF:0000058, GOC:TermGenie, PMID:12242291]
Negative regulation of cytoplasmic translational initiation is a crucial biological process that ensures precise control over protein synthesis within the cytoplasm of cells. This process involves a multifaceted interplay of regulatory mechanisms that fine-tune the initiation of translation, a key step in protein synthesis. At the heart of this regulation lies the intricate dance between translation initiation factors, mRNA structure, and cellular signaling pathways.
Initiation of translation in eukaryotes typically begins with the binding of the small ribosomal subunit (40S) to the 5' cap of mRNA, facilitated by the eukaryotic initiation factor 4F (eIF4F) complex. eIF4F, composed of eIF4E, eIF4A, and eIF4G, plays a pivotal role in recognizing and binding the 5' cap. The 40S subunit then scans the mRNA, searching for the start codon (AUG) where translation will commence. However, negative regulation of this process aims to suppress or dampen this initiation, ensuring that protein synthesis is tightly controlled and occurs only when necessary.
Several mechanisms contribute to the negative regulation of cytoplasmic translational initiation:
1. **eIF4E Inhibition:** eIF4E, a key component of the eIF4F complex, is a critical factor in the initiation process. Its activity can be suppressed by a family of proteins known as eIF4E-binding proteins (4E-BPs). 4E-BPs bind to eIF4E, preventing its interaction with eIF4G and effectively inhibiting the assembly of the eIF4F complex. This inhibition of eIF4F formation disrupts the recruitment of the 40S subunit to the mRNA, leading to a decrease in translation initiation. The phosphorylation state of 4E-BPs plays a crucial role in their binding affinity to eIF4E. When 4E-BPs are unphosphorylated, they bind tightly to eIF4E, inhibiting translation. Conversely, phosphorylation of 4E-BPs reduces their affinity for eIF4E, allowing for the formation of the eIF4F complex and translation initiation.
2. **mRNA Structure:** The structure of mRNA itself can influence its translational efficiency. Certain RNA secondary structures, such as hairpin loops or stem-loop structures, can hinder the scanning of the 40S subunit along the mRNA, thereby reducing the likelihood of finding the start codon and initiating translation. These secondary structures can act as roadblocks, preventing the ribosomal subunit from reaching the start codon.
3. **MicroRNAs (miRNAs):** miRNAs are small non-coding RNAs that play a critical role in gene regulation. They can bind to specific sequences within mRNA, leading to the inhibition of translation. miRNAs often target the 3' untranslated region (3'UTR) of mRNA, where they can block ribosome binding and ultimately suppress translation. This suppression of translation can be achieved through various mechanisms, including mRNA degradation and the inhibition of ribosome movement along the mRNA.
4. **Cellular Signaling Pathways:** Intracellular signaling pathways, particularly those activated by stress or nutrient deprivation, can also contribute to the negative regulation of translation initiation. For instance, the mTOR (mammalian target of rapamycin) signaling pathway, a central regulator of cell growth and metabolism, plays a vital role in modulating translation initiation. When the mTOR pathway is activated, it promotes protein synthesis by phosphorylating various translation initiation factors, including 4E-BPs, leading to their dissociation from eIF4E. However, under stress conditions, such as nutrient deprivation or hypoxia, the mTOR pathway is inhibited. This inhibition leads to the dephosphorylation of 4E-BPs, which then bind to eIF4E, suppressing translation.
Negative regulation of cytoplasmic translational initiation is a complex and dynamic process that is essential for maintaining cellular homeostasis. It allows cells to respond to various stimuli, including changes in nutrient availability, stress signals, and growth factor levels, by modulating the rate of protein synthesis. This precise control over protein production ensures that cells can adapt to their environment and maintain optimal function. By suppressing translation initiation when needed, cells can conserve resources and prevent the accumulation of unnecessary proteins, ultimately contributing to cellular survival and well-being. '
"
Protein | Definition | Taxonomy |
---|---|---|
50S ribosomal protein L31 | A large ribosomal subunit protein bL31 that is encoded in the genome of Escherichia coli K-12. [PRO:DNx, UniProtKB:P0A7M9] | Escherichia coli K-12 |
Compound | Definition | Classes | Roles |
---|---|---|---|
chloramphenicol | Amphenicol: Chloramphenicol and its derivatives. | C-nitro compound; carboxamide; diol; organochlorine compound | antibacterial drug; antimicrobial agent; Escherichia coli metabolite; geroprotector; Mycoplasma genitalium metabolite; protein synthesis inhibitor |
framycetin | framycetin : A tetracyclic antibacterial agent derived from neomycin, being a glycoside ester of neamine and neobiosamine B. Framycetin: A component of NEOMYCIN that is produced by Streptomyces fradiae. On hydrolysis it yields neamine and neobiosamine B. (From Merck Index, 11th ed) | aminoglycoside | allergen; antibacterial drug; Escherichia coli metabolite |
erythromycin | erythromycin : Any of several wide-spectrum macrolide antibiotics obtained from actinomycete Saccharopolyspora erythraea (formerly known as Streptomyces erythraeus). erythromycin A : An erythromycin that consists of erythronolide A having 2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl and 3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl residues attahced at positions 4 and 6 respectively. Erythromycin: A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. | cyclic ketone; erythromycin | |
neamine | neamine : 2-Deoxy-D-streptamine glycosylated at the 4-oxygen with a 6-amino-alpha-D-glucosaminyl group. neamine: fragment of NEOMYCIN B; structure in first source | 2,6-dideoxy-alpha-D-glucoside; aminoglycoside | antibacterial agent |
florfenicol | florfenicol : A carboxamide that is the N-dichloroacetyl derivative of (1R,2S)-2-amino-3-fluoro-1-[4-(methanesulfonyl)phenyl]propan-1-ol. A synthetic veterinary antibiotic that is used for treatment of bovine respiratory disease and foot rot; also used in aquaculture. florfenicol: structure given in first source | organochlorine compound; organofluorine compound; secondary alcohol; secondary carboxamide; sulfone | antimicrobial agent |
antibiotic g 418 | antibiotic G 418: from Micromonospora rhodorangea | ||
paromomycin | paromomycin : An amino cyclitol glycoside that is the 1-O-(2-amino-2-deoxy-alpha-D-glucopyranoside) and the 3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranoside of 4,6-diamino-2,3-dihydroxycyclohexane (the 1R,2R,3S,4R,6S diastereoisomer). It is obtained from various Streptomyces species. A broad-spectrum antibiotic, it is used (generally as the sulfate salt) for the treatment of acute and chronic intestinal protozoal infections, but is not effective for extraintestinal protozoal infections. It is also used as a therapeutic against visceral leishmaniasis. Paromomycin: An aminoglycoside antibacterial and antiprotozoal agent produced by species of STREPTOMYCES. | amino cyclitol glycoside; aminoglycoside antibiotic | anthelminthic drug; antibacterial drug; antiparasitic agent; antiprotozoal drug |
puromycin | puromycins | antiinfective agent; antimicrobial agent; antineoplastic agent; EC 3.4.11.14 (cytosol alanyl aminopeptidase) inhibitor; EC 3.4.14.2 (dipeptidyl-peptidase II) inhibitor; nucleoside antibiotic; protein synthesis inhibitor | |
netilmicin | Netilmicin: Semisynthetic 1-N-ethyl derivative of SISOMYCIN, an aminoglycoside antibiotic with action similar to gentamicin, but less ear and kidney toxicity. | ||
linezolid | acetamides; morpholines; organofluorine compound; oxazolidinone | antibacterial drug; protein synthesis inhibitor | |
zithromax | azithromycin : A macrolide antibiotic useful for the treatment of bacterial infections. Azithromycin: A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis. | macrolide antibiotic | antibacterial drug; environmental contaminant; xenobiotic |
tiamulin | tiamulin : A carbotricyclic compound that is pleuromutilin in which the hydroxyacetate group is replaced by a 2-{[2-(diethylamino)ethyl]sulfanyl}acetate group. An antibacterial drug, tiamulin is used in veterinary medicine (generally as its hydrogen fumarate salt) for the treatment of swine dysentery caused by Serpulina hyodysenteriae. tiamulin: 81723 HFU and tiamutin are for fumarate salt; prevents senescence in ascomycete; pleuromutilin derivative; RN given refers to ((3aS-(3aalpha,4beta,5alpha,6alpha,8beta,9alpha,9abeta,10S*))-isomer | carbotricyclic compound; carboxylic ester; cyclic ketone; organic sulfide; secondary alcohol; semisynthetic derivative; tertiary amino compound; tetracyclic diterpenoid | antibacterial drug |
hmr 3647 | |||
josamycin | acetate ester; aldehyde; disaccharide derivative; glycoside; macrolide antibiotic; tertiary alcohol; tertiary amino compound | antibacterial drug; metabolite | |
albocycline | albocycline: macrolide antibiotic isolated from Streptomyces bruneogriseus nov. sp. MCRL-0129; specifically anti-staphylococcal, including antibiotic-resistant strains; structure | macrolide | |
evernimicin | |||
gentamicin sulfate | |||
pristinamycin iib | virginiamycin M2: structure in first source | ||
cem 101 | solithromycin: an antibacterial fluoroketolide; structure in first source | ||
tetracycline | tetracycline : A broad-spectrum polyketide antibiotic produced by the Streptomyces genus of actinobacteria. Tetracycline: A naphthacene antibiotic that inhibits AMINO ACYL TRNA binding during protein synthesis. | ||
eravacycline | eravacycline: has antibacterial activity | tetracyclines |